PRECISION MEDICINE IN CLINICAL TREATMENT FOR HEPATOCELLULAR CARCINOMA PATIENTS WITH BCLC STAGE C

被引：0
|
作者：
Lin, Chih Wen [1 ,2 ]
Lo, Gio-Ho [1 ]
Lee, Po-Huang [3 ]
Wu, Tsung-Chin [4 ]
Yeh, Jen-Hao [4 ]
Hsiao, Pojen [4 ]
Chen, Yaw-Sen [3 ]
机构：
[1] E Da Hosp, Med, Kaohsiung, Taiwan
[2] I Shou Univ, Kaohsiung, Taiwan
[3] E Da Hosp, Surg, Kaohsiung, Taiwan
[4] E Da Dachang Hosp, Med, Kaohsiung, Taiwan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
368
引用
收藏
页码：234A / 234A
页数：1
相关论文
共 50 条
  • [41] A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma
    Satoshi Kobayashi
    Taito Fukushima
    Makoto Ueno
    Satoshi Moriya
    Makoto Chuma
    Kazushi Numata
    Kota Tsuruya
    Shunji Hirose
    Tatehiro Kagawa
    Nobuhiro Hattori
    Tsunamasa Watanabe
    Kotaro Matsunaga
    Michihiro Suzuki
    Haruki Uojima
    Hisashi Hidaka
    Chika Kusano
    Motoko Suzuki
    Manabu Morimoto
    BMC Cancer, 22
  • [42] Efficacy and Prognostic Factors of Regorafenib in the Treatment of BCLC Stage C Hepatocellular Carcinoma After Failure of the First-Line Therapy
    Xu, Beibei
    Lu, Dong
    Liu, Kaicai
    Lv, Weifu
    Xiao, Jingkun
    Zhang, Xingming
    Zhang, Zhengfeng
    Chai, Jie
    Wang, Lijun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 507 - 518
  • [43] Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion
    Han Wang
    You-Wen Qian
    Meng-Chao Wu
    Wen-Ming Cong
    Journal of Gastrointestinal Surgery, 2020, 24 : 2737 - 2747
  • [44] Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion
    Wang, Han
    Qian, You-Wen
    Wu, Meng-Chao
    Cong, Wen-Ming
    JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 24 (12) : 2737 - 2747
  • [45] Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification
    Kamiyama, Toshiya
    Orimo, Tatsuya
    Wakayama, Kenji
    Shimada, Shingo
    Nagatsu, Akihisa
    Yokoo, Hideki
    Kamachi, Hirofumi
    Yamashita, Kenichiro
    Shimamura, Tsuyoshi
    Taketomi, Akinobu
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [46] Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification
    Toshiya Kamiyama
    Tatsuya Orimo
    Kenji Wakayama
    Shingo Shimada
    Akihisa Nagatsu
    Hideki Yokoo
    Hirofumi Kamachi
    Kenichiro Yamashita
    Tsuyoshi Shimamura
    Akinobu Taketomi
    World Journal of Surgical Oncology, 15
  • [47] Lenvatinib plus hepatic arterial infusion of modified FOLFOX regime(FOHAIC) in patients with BCLC stage C hepatocellular carcinoma.
    Mai, Qicong
    Shi, Feng
    Chen, Xiaoming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16000 - E16000
  • [48] New Advances in Precision Medicine for Hepatocellular Carcinoma Recurrence Prediction and Treatment
    Vilarinho, Silvia
    Calvisi, Diego F.
    HEPATOLOGY, 2014, 60 (06) : 1812 - 1814
  • [49] Liver-Directed Concurrent Chemoradiotherapy vs. Sorafenib for BCLC Stage C Hepatocellular Carcinoma
    Kim, J.
    Kim, T. H.
    Byun, H. K.
    Seong, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E51 - E51
  • [50] Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages
    D'Avola, Delia
    Inarrairaegui, Mercedes
    Pardo, Fernando
    Rotellar, Fernando
    Marti, Pablo
    Bilbao, Jose I.
    Martinez-Cuesta, Antonio
    Benito, Alberto
    Alegre, Felix
    Mauleon, Erica
    Herrero, Jose I.
    Quiroga, Jorge
    Prieto, Jesus
    Sangro, Bruno
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (07) : 1964 - 1971
12345